Skip to main content
. 2023 Apr 29;12(5):1033. doi: 10.3390/antiox12051033

Figure 3.

Figure 3

In vivo Evaluation of effects (mean ± SD) of compounds 3aa and 3bc (1 and 10 mg/kg, p.o.) on scopolamine-induced cognitive deficits (1 mg/kg, i.p.) in comparison with donepezil (5 mg/kg, p.o.). Results were analyzed by ANOVA. n = 10 per group, **** p < 0.0001 versus vehicle control group, # p < 0.05 and #### p < 0.0001 versus scopolamine treated group.